Package Leaflet: Information for the User
Levitra 20 mg Film-Coated Tablets
vardenafil
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
Levitra contains vardenafil, which belongs to a group of medicines called phosphodiesterase 5 inhibitors. These medicines are used to treat erectile dysfunction in adult men, a condition which is also known as impotence. At least one in ten men has trouble getting or keeping an erection at some time. This can be due to physical or psychological causes, or a combination of both. Regardless of the cause, the blood vessels and muscles in the penis are affected, resulting in impaired blood flow, which is necessary to achieve and maintain an erection.
Levitra will only work when you are sexually stimulated. This medicine reduces the action of a natural chemical in your body called phosphodiesterase type 5, which is found primarily in the penis. Levitra helps to increase blood flow into the penis to achieve and maintain an erection when sexually stimulated.
Do not take Levitra
Warnings and precautions
Before taking Levitra, tell your doctor if you have:
Be aware of the following
Children and adolescents
Levitra should not be used in children and adolescents under 18 years of age.
Other medicines and Levitra
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
Some medicines may cause problems if taken with Levitra. These medicines include:
Do not take Levitra film-coated tablets in combination with any other medicine for erectile dysfunction, including Levitra orodispersible tablets.
Taking Levitra with food, drinks, and alcohol
You can take Levitra with or without food, but if you have a meal with a high fat content, it may take longer to work.
Pregnancy and breastfeeding
Levitra should not be used in women.
Driving and using machines
Levitra may cause dizziness or affect your vision. Do not drive or operate machinery if you experience dizziness or vision changes after taking Levitra.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is 10 mg.
Take a Levitra tablet about 25 to 60 minutes before sexual activity. With sexual stimulation, you may achieve an erection from 25 minutes up to 4-5 hours after taking Levitra.
Do not take Levitra film-coated tabletswith any other formulation of Levitra.
Do not take Levitramore than once a day.
If you think that the effect of Levitra is too strong or too weak, talk to your doctor.
If you take more Levitra than you should
Taking too much Levitra may cause more side effects. If you take more Levitra than you should, tell your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Most of the side effects are mild or moderate.
Some patients have reported a sudden decrease or loss of vision in one or both eyes after taking Levitra. If you experience a sudden loss of vision, stop taking Levitra and contact your doctor immediately.
Some patients have reported a sudden decrease or loss of hearing after taking Levitra.
There have been reports of sudden death, fast or irregular heartbeat, heart attack, chest pain, and stroke in men taking vardenafil. Most of these men had pre-existing heart problems. It is not possible to determine whether these events were directly related to vardenafil.
The likelihood of experiencing side effects may be affected by the dose and individual susceptibility.
Very common side effects (may affect up to 1 in 10 people)
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Very rare side effects (may affect less than 1 in 10,000 people) or frequency not known
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after "EXP". The expiry date refers to the last day of that month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
What Levitra contains
In the tablet core: crospovidone, magnesium stearate, microcrystalline cellulose, anhydrous colloidal silica.
In the film coating: macrogol 400, hypromellose, titanium dioxide (E171), yellow iron oxide (E172), red iron oxide (E172).
Appearance and packaging
Levitra 20 mg film-coated tablets are orange, round, and marked with the Bayer cross on one side and the strength (20) on the other. The tablets are available in packs of 2, 4, 8, 12, or 20 tablets. Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Bayer AG
51368 Leverkusen
Germany
Manufacturer
Bayer AG
Kaiser-Wilhelm-Allee
51368 Leverkusen
Germany
For further information on this medicine, contact the local representative of the marketing authorization holder.
Belgium/Belgique/Belgien | Lithuania |
Bayer SA-NV | UAB Bayer |
Tel: +32-(0)2-535 63 11 | Tel: +370 523 36 868 |
Bulgaria | Luxembourg/Luxemburg |
Bayer Bulgaria EOOD | Bayer SA-NV |
Tel: +359-(0)2-424 72 80 | Tel: +32-(0)2-535 63 11 |
Czech Republic | Hungary |
Bayer s.r.o. | Bayer Hungária KFT |
Tel: +420 266 101 111 | Tel: +36 14 87-4100 |
Denmark | Malta |
Bayer A/S | Alfred Gera and Sons Ltd. |
Tel: +45 45 23 50 00 | Tel: +35 621 44 62 05 |
Germany | Netherlands |
Jenapharm GmbH & Co. KG | Bayer B.V. |
Tel: +49 (0)3641-87 97 444 | Tel: +31-(0)297-28 06 66 |
Estonia | Norway |
Bayer OÜ | Bayer AS |
Tel: +372 655 85 65 | Tel: +47-23 13 05 00 |
Greece | Austria |
Bayer Ελλάς ΑΒΕΕ | Bayer Austria Ges. m. b. H. |
Tel: +30 210 61 87 500 | Tel: +43-(0)1-711 46-0 |
Spain | Poland |
Bayer Hispania S.L. | Bayer Sp. z o.o. |
Tel: +34-93-495 65 00 | Tel: +48 22 572 35 00 |
France | Portugal |
Bayer HealthCare | Bayer Portugal, Lda. |
Tel: +33-(0)800 87 54 54 | Tel: +351 21 416 42 00 |
Croatia | Romania |
Bayer d.o.o. | SC Bayer SRL |
Tel: +385-(0)1-6599 900 | Tel: +40-21-529 59 00 |
Ireland | Slovenia |
Bayer Limited | Bayer d.o.o. |
Tel: +353 1 216 3300 | Tel: +386 (0)1 58 14 400 |
Iceland | Slovakia |
Icepharma hf. | Bayer, spol. s r.o. |
Tel: +354-540 8000 | Tel: +421 2-59 21 31 11 |
Italy | Finland |
Bayer S.p.A. | Bayer Oy |
Tel: +39 02 397 81 | Tel: +358-20 785 21 |
Cyprus | Sweden |
NOVAGEM Limited | Bayer AB |
Tel: +357 22 48 38 58 | Tel: +46 (0)8 580 223 00 |
Latvia | United Kingdom |
SIA Bayer | Bayer plc |
Tel: +371 67 845 563 | Tel: +44 (0) 118 206 3000 |
Date of last revision of this leaflet {month, year}
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu